Investors & Media Contact Us Linkedin Twitter Who We Are Focus Areas Pipeline Patients Careers Rare Oncology Too many loved ones live with uncertainty. Let’s find answers. Rare oncology is where rare diseases and cancers meet. While some rare tumors are not malignant, their presence and progression are nonetheless devastating for patients. At SpringWorks, we are relentless in the search for answers because people with these often-overlooked conditions can’t wait. Let’s innovate for the overlooked Our late-stage rare oncology programs have the potential to be best-in-class treatments for patients with devastating diseases, including desmoid tumors, neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN) and low-grade gliomas. LEARN MORE LEARN MORE LEARN MORE LEARN MORE LEARN MORE Linkedin Twitter Who We Are Leadership & Board Mission & Values Partners & Collaborators Focus Areas Rare Oncology BCMA Combinations in Multiple Myeloma Biomarker-Defined Metastatic Solid Tumors Pipeline Nirogacestat Mirdametinib Clinical Trials Investigator-Initiated Research Careers View Opportunities Patients Desmoid Tumors NF1-PN Expanded Access Contact Investors & Media Press Releases Events & Presentations Corporate Governance Financial Information Stock Information Investor Resources © 2021 SpringWorks Therapeutics. All rights reserved. Privacy Policy Terms of Use By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies